1. PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
    Xiaohong Liu et al, 2024, Pharmacological Research CrossRef
  2. Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer
    Canhui Cao et al, 2024, Cancer Letters CrossRef
  3. The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
    Xin Xie et al, 2022, Translational Oncology CrossRef
  4. The Role of Gut Microbiota in Tumor Immunotherapy
    Miao Wu et al, 2021, Journal of Immunology Research CrossRef
  5. Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
    Maria I. Mosquera-Heredia et al, 2021, Biomedicines CrossRef
  6. PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas
    Zhichao Tian et al, 2022, Frontiers in Immunology CrossRef
  7. Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
    Maysaa Abdulla et al, 2023, Biomolecules CrossRef
  8. Hot and cold tumors: Immunological features and the therapeutic strategies
    Lianjie Wang et al, 2023, MedComm CrossRef
  9. TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas
    Diane Libert et al, 2024, American Journal of Surgical Pathology CrossRef
  10. Boosting Anti-tumour Immunity Using Adjuvant Apigenin
    Chuli Xiao et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  11. PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
    Katarzyna Malinowska et al, 2023, Journal of Clinical Medicine CrossRef
  12. Engagement of CD300c by a novel monoclonal antibody induces the differentiation of monocytes to M1 macrophages
    Su In Lee et al, 2024, Immunobiology CrossRef
  13. Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
    Yuanyuan Liu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  14. The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
    Xianjing Chu et al, 2022, Frontiers in Immunology CrossRef
  15. VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma
    Andreea Cătălina Tinca et al, 2022, Medicina CrossRef